A science lesson in secure investing
Before the onset of Covid-19 the life sciences sector was experiencing high levels of investment and rapid innovation. Months into…
Latest Investment
-
4 months
-
5 months
-
6 months
-
6 months
-
4 months
-
5 months
-
6 months
-
6 months
The big interview: Cisco UK and Ireland CEO David Meads
Foreseeing a global pandemic is not in any business leader’s job description. But perhaps the most vital skill for today’s…
Latest News
View More
Lilly and Boehringer report positive outcomes in heart failure trial
Eli Lilly and Boehringer Ingelheim have reported that new exploratory sub-analysis data from the EMPEROR-Reduced Phase III trial showed Jardiance (empagliflozin) helped reduce the risk…
Dicerna’s nedosiran achieves urinary oxalate normalisation in PH trial
Dicerna Pharmaceuticals has reported positive interim data from its ongoing PHYOX3 trial of investigational drug candidate, nedosiran, for the treatment of three known types of primary…
Goldfinch Bio reports positive data from GFB-887 trial
Goldfinch Bio has reported positive results from its Phase I clinical trial of GFB-887, a highly potent and selective inhibitor…
Moderna completes enrolment for mRNA-1273 trial against Covid-19
Moderna has completed the enrolment of participants for the Phase III COVE study of its vaccine candidate, mRNA-1273, against Covid-19.…
Daiichi Sankyo begins oncology therapy trial for metastatic tumours
Daiichi Sankyo has dosed the first patient in a first-in-human global Phase I trial to evaluate a Glycoprotein-A Repetitions Predominant…
Participant in AstraZeneca’s Brazilian Covid-19 trial dies
Brazilian health agency Anvisa has announced that a volunteer in the Brazilian trial of AstraZeneca and Oxford University’s investigational Covid-19…
Latest Content
View MoreWAKIX (pitolisant) for the Treatment of Cataplexy with Narcolepsy
WAKIX® (pitolisant) is the first and only non-scheduled medication indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS)…
Real Time Cargo Intelligence to Increase Distribution Quality and Security
Smooth visibility from the place of production to the ultimate destination must be the new standard for vaccine delivery. The…
SIMPONI ARIA (golimumab) for the Treatment of Polyarticular Juvenile Idiopathic Arthritis (pJIA)
SIMPONI ARIA® (golimumab) is a fully human anti-tumour necrosis factor (TNF) alpha monoclonal antibody. It is indicated for the treatment…
SOM Biotech Announces Poster Presentation on the Repurposing of Eravacycline for the Treatment of SARS-CoV-2
SOM Biotech, a biopharmaceutical company specialising in the repositioning of existing drugs for the treatment of diseases with a high…